## Fetal Lung Maturity and Surfactant Production Timeline **Key Point:** Adequate surfactant production for prevention of RDS occurs at approximately 35–37 weeks of gestation in most infants. This is the threshold for "fetal lung maturity." ### Developmental Milestones in Surfactant Synthesis | Gestational Age | Surfactant Status | Clinical Significance | |---|---|---| | <28 weeks | Minimal/absent | Very high RDS risk (>90%) | | 28–32 weeks | Emerging, inadequate | High RDS risk (50–80%) | | 32–35 weeks | Increasing, variable | Moderate RDS risk (25–50%) | | **35–37 weeks** | **Adequate in most** | **Low RDS risk (<10%)** | | >37 weeks | Mature, abundant | Minimal RDS risk (<5%) | **High-Yield:** The critical inflection point is 34 weeks — infants born before 34 weeks have significantly elevated RDS risk and often require exogenous surfactant replacement. By 35–37 weeks, most infants have sufficient endogenous surfactant. ### Factors Accelerating Surfactant Maturation 1. Maternal corticosteroids (antenatal betamethasone/dexamethasone) — accelerate maturation by 1–2 weeks 2. Maternal hypertension and preeclampsia 3. Placental insufficiency 4. Intrauterine growth restriction (IUGR) ### Factors Delaying Surfactant Maturation 1. Maternal diabetes (especially poor glycemic control) 2. Maternal obesity 3. Cesarean delivery without labor **Mnemonic:** **SURFACTANT READY AT 35** — A practical rule for clinicians: at 35 weeks, assume adequate surfactant in most cases; before 34 weeks, assume risk and prepare for RDS. **Clinical Pearl:** The L/S ratio (lecithin-to-sphingomyelin) on amniotic fluid is used to confirm lung maturity: L/S >2:1 indicates maturity (typically achieved by 35 weeks). [cite:Nelson Textbook of Pediatrics 21e Ch 102] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.